H Booth, I Richmond, C Ward, PV Gardiner, R Harkawat and EH Walters
Respiratory Immunology Group, Alfred Hospital, Victoria, Australia.

Inhaled corticosteroids are now first-line therapy for most patients with asthma. However, it has been shown that there is ongoing airway inflammation and airway hyperresponsiveness even in the presence of low dose inhaled corticosteroids. To ensure a maximal therapeutic potential we investigated the effect of 3 mo of a very high dose of a new inhaled corticosteroid, fluticasone propionate (FP) (equivalent to 4,000 micrograms daily of beclomethasone dipropionate [BDP]. Twenty asthmatics with mild-to-moderate disease were recruited into this single-blind study. Baseline data were compared with those from 26 normal subjects. Differences in inflammatory indices between asthmatics and normal subjects were detected in both BAL and endobronchial biopsies. After the FP treatment period there was a significant improvement in symptom scores, lung function, and airway responsiveness by a mean 2.8 doubling dilutions of methacholine. Reduction in the airway lymphocyte load and lymphocyte activation was demonstrated and is likely to be an important mechanism mediating the effects of inhaled corticosteroids. Decreased mast cell numbers and activity in atopic asthma suggest that corticosteroids may have additional targets in different types of asthma. Reduced lymphocyte and mast cell activity was found with high dose FP even in those receiving low dose maintenance BDP prior to the study, suggesting a dose-response effect of inhaled corticosteroids on airway inflammation. BAL eosinophilia was still present after FP, indicative of a component of asthmatic airway inflammation that is relatively resistant to corticosteroid therapy.

This article has been cited by other articles:

				H. Kanazawa, S. Nomura, and K. Asai Roles of Angiopoietin-1 and Angiopoietin-2 on Airway Microvascular Permeability in Asthmatic Patients Chest, April 1, 2007; 131(4): 1035 - 1041. [Abstract] [Full Text] [PDF]

				G.P. Currie, P. Srivastava, O.J. Dempsey, and D.K.C. Lee Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists QJM, March 1, 2005; 98(3): 171 - 182. [Abstract] [Full Text] [PDF]

				P. Chanez, A. Bourdin, I. Vachier, P. Godard, J. Bousquet, and A. M. Vignola Effects of Inhaled Corticosteroids on Pathology in Asthma and Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2004; 1(3): 184 - 190. [Abstract] [Full Text] [PDF]

				A. ten Brinke, A. H. Zwinderman, P. J. Sterk, K. F. Rabe, and E. H. Bel "Refractory" Eosinophilic Airway Inflammation in Severe Asthma: Effect of Parenteral Corticosteroids Am. J. Respir. Crit. Care Med., September 15, 2004; 170(6): 601 - 605. [Abstract] [Full Text] [PDF]

				G. Riccioni, C. Di Ilio, and N. D'Orazio Pharmacological Treatment of Airway Remodeling: Inhaled Corticosteroids or Antileukotrienes? Ann. Clin. Lab. Sci., April 1, 2004; 34(2): 138 - 142. [Abstract] [Full Text] [PDF]

				G. P. Currie, D. K. C. Lee, K. Haggart, C. E. Bates, and B. J. Lipworth Effects of Montelukast on Surrogate Inflammatory Markers in Corticosteroid-treated Patients with Asthma Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1232 - 1238. [Abstract] [Full Text] [PDF]

				A. Chetta, A. Zanini, A. Foresi, M. Del Donno, A. Castagnaro, R. D'Ippolito, S. Baraldo, R. Testi, M. Saetta, and D. Olivieri Vascular Component of Airway Remodeling in Asthma Is Reduced by High Dose of Fluticasone Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 751 - 757. [Abstract] [Full Text] [PDF]

				A. Kibe, H. Inoue, S. Fukuyama, K. Machida, K. Matsumoto, H. Koto, T. Ikegami, H. Aizawa, and N. Hara Differential Regulation by Glucocorticoid of Interleukin-13-induced Eosinophilia, Hyperresponsiveness, and Goblet Cell Hyperplasia in Mouse Airways Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 50 - 56. [Abstract] [Full Text] [PDF]

				C Ward, M Pais, R Bish, D Reid, B Feltis, D Johns, and E H Walters Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma Thorax, April 1, 2002; 57(4): 309 - 316. [Abstract] [Full Text] [PDF]

				G W Chalmers, K J Macleod, S A Little, L J Thomson, C P McSharry, and N C Thomson Influence of cigarette smoking on inhaled corticosteroid treatment in mild asthma Thorax, March 1, 2002; 57(3): 226 - 230. [Abstract] [Full Text] [PDF]

				J.D. Leuppi, C.M. Salome, C.R. Jenkins, H. Koskela, J.D. Brannan, S.D. Anderson, M. Andersson, H.K. Chan, and A.J. Woolcock Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma Eur. Respir. J., September 1, 2001; 18(3): 444 - 450. [Abstract] [Full Text] [PDF]

				B. E. ORSIDA, C. WARD, X. LI, R. BISH, J. W. WILSON, F. THIEN, and E. H. WALTERS Effect of a Long-acting {beta}2-Agonist over Three Months on Airway Wall Vascular Remodeling in Asthma Am. J. Respir. Crit. Care Med., July 1, 2001; 164(1): 117 - 121. [Abstract] [Full Text] [PDF]

				S. S. Salvi, M. T. Krishna, A. P. Sampson, and S. T. Holgate The Anti-inflammatory Effects of Leukotriene-Modifying Drugs and Their Use in Asthma Chest, May 1, 2001; 119(5): 1533 - 1546. [Abstract] [Full Text] [PDF]

				W. J. CALHOUN, K. L. HINTON, and J. J. KRATZENBERG The Effect of Salmeterol on Markers of Airway Inflammation Following Segmental Allergen Challenge Am. J. Respir. Crit. Care Med., March 15, 2001; 163(4): 881 - 886. [Abstract] [Full Text]

				W. W. Busse and R. F. Lemanske Asthma N. Engl. J. Med., February 1, 2001; 344(5): 350 - 362. [Full Text] [PDF]

				J. D. LEUPPI, C. M. SALOME, C. R. JENKINS, S. D. ANDERSON, W. XUAN, G. B. MARKS, H. KOSKELA, J. D. BRANNAN, R. FREED, M. ANDERSSON, et al. Predictive Markers of Asthma Exacerbation during Stepwise Dose Reduction of Inhaled Corticosteroids Am. J. Respir. Crit. Care Med., February 1, 2001; 163(2): 406 - 412. [Abstract] [Full Text]

				H. Bisgaard Leukotriene Modifiers in Pediatric Asthma Management Pediatrics, February 1, 2001; 107(2): 381 - 390. [Abstract] [Full Text]

				S. PEDERSEN Why Does Airway Inflammation Persist? Is It Failure to Treat Early? Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): S182 - 185. [Full Text] [PDF]

				R. LOUIS, L. C. K. LAU, A. O. BRON, A. C. ROLDAAN, and M. RADERMECKER The Relationship between Airways Inflammation and Asthma Severity Am. J. Respir. Crit. Care Med., January 1, 2000; 161(1): 9 - 16. [Abstract] [Full Text]

				X. LI, C. WARD, F. THIEN, R. BISH, T. BAMFORD, X. BAO, M. BAILEY, J. W. WILSON, and E. HAYDN WALTERS An Antiinflammatory Effect of Salmeterol, a Long-acting beta 2 Agonist, Assessed in Airway Biopsies and Bronchoalveolar Lavage in Asthma Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): 1493 - 1499. [Abstract] [Full Text]

				C. MARGUET, F. JOUEN-BOEDES, T. P. DEAN, and J. O. WARNER Bronchoalveolar Cell Profiles in Children with Asthma, Infantile Wheeze, Chronic Cough, or Cystic Fibrosis Am. J. Respir. Crit. Care Med., May 1, 1999; 159(5): 1533 - 1540. [Abstract] [Full Text] [PDF]

				B. E Orsida, X. Li, B. Hickey, F. Thien, J. W Wilson, and E H. Walters Vascularity in asthmatic airways: relation to inhaled steroid dose Thorax, April 1, 1999; 54(4): 289 - 295. [Abstract] [Full Text]

				A. Jatakanon, S. Kharitonov, S. Lim, and P. J Barnes Effect of differing doses of inhaled budesonide on markers of airway inflammation in patients with mild asthma Thorax, February 1, 1999; 54(2): 108 - 114. [Abstract] [Full Text]

				J. L Faul, C. T Leonard, C. M Burke, V. J Tormey, and L. W Poulter Fluticasone propionate induced alterations to lung function and the immunopathology of asthma over time Thorax, September 1, 1998; 53(9): 753 - 761. [Abstract] [Full Text]

				C. WARD, G. I. SNELL, L. ZHENG, B. ORSIDA, H. WHITFORD, T. J. WILLIAMS, and E. HAYDN WALTERS Endobronchial Biopsy and Bronchoalveolar Lavage in Stable Lung Transplant Recipients and Chronic Rejection Am. J. Respir. Crit. Care Med., July 1, 1998; 158(1): 84 - 91. [Abstract] [Full Text] [PDF]

				J. A. Hotchkiss, R. Hilaski, H. Cho, K. Regan, P. Spencer, K. Slack, and J. R. Harkema Fluticasone Propionate Attenuates Ozone-induced Rhinitis and Mucous Cell Metaplasia in Rat Nasal Airway Epithelium Am. J. Respir. Cell Mol. Biol., January 1, 1998; 18(1): 91 - 99. [Abstract] [Full Text]

				S. E. WENZEL, S. J. SZEFLER, D. Y. M. LEUNG, S. I. SLOAN, M. D. REX, and R. J. MARTIN Bronchoscopic Evaluation of Severe Asthma . Persistent Inflammation Associated with High Dose Glucocorticoids Am. J. Respir. Crit. Care Med., September 1, 1997; 156(3): 737 - 743. [Abstract] [Full Text] [PDF]

				L. M. FABBRI, G. CARAMORI, B. BEGHÉ, A. PAPI, and A. CIACCIA Physiologic Consequences of Long-term Inflammation Am. J. Respir. Crit. Care Med., May 1, 1997; 157(5): 195 - 198. [Full Text]